“…In preclinical and clinical investigations, ECM scaffolds are frequently used for reconstructive and regenerative applications (Brown and Badylak, 2014;Aamodt and Grainger, 2016;Nowocin et al, 2016;Xu et al, 2017;Jiang et al, 2021;Anderson et al, 2022;Barbon et al, 2022;Barbulescu et al, 2022;Wang et al, 2022b;Yesantharao and Nguyen, 2022;Zhang et al, 2022;Shakeel and Corridon, 2023a). Naturally occurring ECM-based biopolymers derived from harvested human (Kumar Kuna et al, 2018) and animal (Kumar Kuna et al, 2018) organs and tissues, as well as agarose (Salati et al, 2020), alginate (Ahmad Raus et al, 2021), chitosan (Sultankulov et al, 2019), and cellulose (Silva et al, 2022), can stimulate angiogenesis, growth, and differentiation of repopulating cells.…”